Apmonia Therapeutics raised €10M series A with Capital Grand Est, Finovam Gestion, Fondation Fournier-Majoie, Angels Santé, Capital Cell in France
09 January 2026
09 January 2026
Total investments received (USD): 21.75M
Round value (USD): 11.73M
Company: Apmonia Therapeutics
Related deals
ErVimmune raised €17 million Series A financing with Seventure and SPRIM Global
Investments
06 January 2026
EVerZom raised €10M series A with Capital Grand Est, European Innovation Council Fund
Investments
03 October 2025
StemInov raised €10.6M with Angels Santé, Business Angels des Grandes Écoles, Alsace Business Angels, Codexial, Finovam Gestion, ILP
Investments
15 September 2025
Tafalgie Therapeutics secured €12 million in a Series A funding round with Bpifrance and the EIC FUnd
Investments
04 September 2025
SafeHeal to raise €10 million series C extension led by Asabys Partners through its Sabadell Asabys II fund
Investments
01 September 2025
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
Ireland
Italy
Portugal
United Kingdom